Geoffrey Christian Jocelyn Appelboom, MD
Neurosurgery · Paterson
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Neurosurgical Associates of New Jersey, P.C. · 42 clinicians in this group
Hospitals listed: St Joseph'S University Medical Center Inc. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Appelboom’s office at (973) 782-9175 to ask if they take your plan before you enroll.
State licence records
1 licence
- New Jersey 25MA10265400Medical Doctor · since 2018 · expires 2027-06-30ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Joseph'S University Medical Center IncPaterson, NJAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Saint Josephs Health, which runs 2 hospitalsPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.372, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.154, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.235, Oct 2024 – Sep 2025
See every measure and the patient survey for St Joseph'S University Medical Center Inc
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.372 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.154 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.48 (0.53 to 2.44) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.73 (0.45 to 1.02) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 196.42 (150.15 to 242.7) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 670 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 483 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,651 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.38) · 6,389 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 6,583 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.73 (0.68 to 4.78) · 1,291 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.73 (0.17 to 3.28) · 447 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.44 (0.96 to 3.92) · 1,293 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.29 (2.42 to 14.17) · 479 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.63 (0.01 to 7.25) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.11) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.1 (0 to 0.65) · 6,154 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 41 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.459 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.697 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 336 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 904 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 48.7 · 168 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 69 · 471 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 58.3 · 682 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 1,175 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.6 to 8.7) · 41 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8 to 16.2) · 41 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.2 · 50 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 208 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.2 to 15.8) · 804 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 326 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,521 patients answered, 11% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$83,809
Medicare paid this office $83,809 for 175 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Fusion of upper spine bone with removal of disc and release of spinal cord or nerve, 1 disc | 14 | $17,936 | $1,281 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 15 | $8,875 | $555 |
| New patient visit (45+ min) | 55 | $7,969 | $145 |
| Placement of stabilizing device to front, 2-3 spine bone segments | 13 | $6,927 | $533 |
| Short return visit (20+ min) | 60 | $5,837 | $77 |
See all 9 services
| Fusion of upper spine bone with removal of disc and release of spinal cord or nerve, 1 disc | 14 | $17,936 | $1,281 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 15 | $8,875 | $555 |
| New patient visit (45+ min) | 55 | $7,969 | $145 |
| Placement of stabilizing device to front, 2-3 spine bone segments | 13 | $6,927 | $533 |
| Short return visit (20+ min) | 60 | $5,837 | $77 |
| New patient visit (30+ min) | 55 | $5,242 | $95 |
| Insertion of cage or mesh device to spine bone and disc space during spine fusion | 18 | $5,175 | $185 |
| Return visit (30+ min) | 26 | $2,906 | $108 |
| Short return visit | 11 | $547 | $50 |
Procedures Medicare counted
| Laminectomy or laminotomy (partial removal of spine bones) | 22 | More than 51% of doctors who do this |
| Spinal fusion | 84 | More than 68% of doctors who do this |
Who their Medicare patients are
175 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 9% · Women 47% · Also on Medicaid 8% · Health risk score 1.10. At or below the middle of the specialty; the typical neurosurgery clinician is at 1.46.
Conditions among them: High blood pressure 74% · Coronary heart disease 41% · Diabetes 38% · Depression 34% · Chronic kidney disease 26% · Atrial fibrillation 15% · Cancer 14% · COPD 14% · Heart failure 13% · Stroke 11% · Dementia 8%.
The office billed $2,689,808, Medicare allowed $105,661 and paid $83,809; for 357 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 175 | 357 | 73 | 1.10 | $2,689,808 | $83,809 |
| 2023 | 157 | 321 | 73 | 1.20 | $2,306,030 | $82,849 |
| 2022 | 108 | 234 | 71 | 1.20 | $1,602,794 | $61,478 |
| 2021 | 82 | 193 | 72 | 1.16 | $782,551 | $36,911 |
| 2020 | 68 | 161 | 74 | 2.11 | $810,170 | $40,316 |
| 2019 | 88 | 159 | 77 | 1.88 | $1,187,171 | $54,510 |
| 2018 | 61 | 110 | 71 | 1.45 | $311,133 | $19,659 |
| 2017 | 15 | 16 | 71 | 1.10 | $8,096 | $1,824 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 20 | $12,759 | $638 |
| New patient visit (45+ min) | 41 | $5,881 | $143 |
| Short return visit (20+ min) | 45 | $4,805 | $77 |
| Insertion of cage or mesh device to spine bone and disc space during spine fusion | 13 | $4,776 | $191 |
| New patient visit (30+ min) | 48 | $4,389 | $91 |
| Return visit (30+ min) | 24 | $2,690 | $108 |
2022: 4 services
| New patient visit (45+ min) | 30 | $4,290 | $143 |
| New patient visit (30+ min) | 34 | $3,280 | $96 |
| Short return visit (20+ min) | 31 | $3,193 | $80 |
| Return visit (30+ min) | 16 | $1,905 | $106 |
2021: 2 services
| New patient visit (30+ min) | 37 | $3,588 | $97 |
| Short return visit (20+ min) | 33 | $3,068 | $73 |
2020: 2 services
| New patient visit (30+ min) | 27 | $2,580 | $96 |
| Short return visit (20+ min) | 21 | $1,649 | $61 |
2019: 3 services
| Critical care, first 30-74 minutes | 18 | $4,028 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,808 | $176 |
| New patient visit (30+ min) | 26 | $2,511 | $97 |
2018: 2 services
| Short return visit (20+ min) | 24 | $1,181 | $44 |
| New patient visit (30+ min) | 14 | $959 | $68 |
Drugs they prescribed that Part D paid
$1,239
Pharmacies billed $1,239 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 28% of their Part D prescriptions (43 of 154) in 2024. Above the middle of the specialty; the typical neurosurgery clinician is at 28%.
154 generic and 0 brand-name prescriptions · $1,239 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ibuprofen | 37 | $238 | $6 |
| Oxycodone-Acetaminophen | 12 | $192 | $16 |
| Cyclobenzaprine | 19 | $178 | $9 |
| Pregabalin | 11 | $130 | $12 |
| Meloxicam | 12 | $85 | $7 |
See all 6 drugs
| Ibuprofen | 37 | $238 | $6 |
| Oxycodone-Acetaminophen | 12 | $192 | $16 |
| Cyclobenzaprine | 19 | $178 | $9 |
| Pregabalin | 11 | $130 | $12 |
| Meloxicam | 12 | $85 | $7 |
| Tramadol | 27 | $81 | $3 |
Year by year
| 2024 | 154 | 38 | 28% (43) | 0% | $1,239 |
| 2023 | 192 | 62 | 26% (49) | None | $4,348 |
| 2022 | 150 | 42 | 32% (48) | 0% | $1,964 |
| 2021 | 39 | 17 | None | 0% | $492 |
| 2020 | 19 | None | None | 0% | $87 |
| 2019 | 34 | 14 | None | None | $1,328 |
| 2017 | 11 | None | 0% (0) | None | $267 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Gabapentin | 20 | $321 | $16 |
| Tramadol | 24 | $311 | $13 |
| Cyclobenzaprine | 33 | $239 | $7 |
| Ibuprofen | 14 | $87 | $6 |
| Oxycodone-Acetaminophen | 14 | $71 | $5 |
2022: 5 drugs
| Tramadol | 34 | $366 | $11 |
| Pregabalin | 12 | $296 | $25 |
| Gabapentin | 20 | $267 | $13 |
| Ibuprofen | 22 | $168 | $8 |
| Diazepam | 12 | $35 | $3 |
Money from drug and device companies
$2,206 in 2025
| 2025 | 9 | 18 | None | $2,206 |
| 2024 | 6 | 10 | None | $1,580 |
| 2023 | 8 | 13 | None | $770 |
| 2022 | 5 | 13 | None | $1,004 |
| 2021 | 11 | 24 | None | $2,546 |
| 2020 | 6 | 26 | None | $2,009 |
| 2019 | 7 | 36 | None | $3,168 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Centinel Spine | Prodisc L | $776 | 3 payments
|
| Stryker | Cascadia Interbody System | $482 | 3 payments
|
| Royal Biologics | None | $267 | 1 payment
|
| Alphatec Spine | Other - Miscellaneous | $171 | 2 payments
|
| VB Spine | Es2 Spinal System | $148 | 1 payment
|
| Globus Medical | Senza | $136 | 3 payments
|
See all 18 published payments
| Globus Medical | Meals · 2025-08-21 | Senza | $24 |
| Royal Biologics | Meals · 2025-08-14 | None | $267 |
| Intrinsic Therapeutics | Meals · 2025-08-07 | Barricaid Acd (Annular Closure Device) | $25 |
| Globus Medical | Meals · 2025-08-04 | Senza | $8 |
| Intrinsic Therapeutics | Meals · 2025-07-23 | Barricaid Acd (Annular Closure Device) | $40 |
| VB Spine | Meals · 2025-07-17 | Es2 Spinal System | $148 |
| Intrinsic Therapeutics | Meals · 2025-06-24 | Barricaid Acd (Annular Closure Device) | $5 |
| Alphatec Spine | Meals · 2025-06-02 | Lif | $34 |
| Inspire Medical Systems | Meals · 2025-04-07 | Inspire | $23 |
| Centinel Spine | Meals · 2025-04-04 | Prodisc L | $216 |
| Centinel Spine | Travel · 2025-03-29 | Prodisc L | $196 |
| Centinel Spine | Travel · 2025-03-17 | Prodisc L | $364 |
| Globus Medical | Meals · 2025-03-03 | Senza | $104 |
| Stryker | Meals · 2025-02-26 | Cascadia Interbody System | $169 |
| Stryker | Meals · 2025-02-12 | Cascadia Interbody System | $160 |
| Stryker | Meals · 2025-02-07 | Cascadia Interbody System | $153 |
| Qapel Medical | Meals · 2025-01-30 | None | $133 |
| Alphatec Spine | Meals · 2025-01-13 | Other - Miscellaneous | $137 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,580
| Stryker | Capri Corpectomy Cage System | $1,457 | 4 payments
|
| Providence Medical Technology | None | $38 | 2 payments
|
| Sanara MedTech | Celleraterx | $24 | 1 payment
|
| Alphatec Spine | Identiti | $22 | 1 payment
|
| Spinal Elements | Medical Devices | $21 | 1 payment
|
| Biotronik Nro | Prospera | $18 | 1 payment
|
2023: $770
| Alphatec Spine | Other - Miscellaneous | $211 | 2 payments
|
| Si-Bone | None | $188 | 3 payments
|
| NuVasive | Acp | $143 | 1 payment
|
| Stryker | Vsp System, Vsp Cranial | $114 | 2 payments
|
| Biotronik Nro | Biotronik | $53 | 2 payments
|
| Providence Medical Technology | None | $25 | 1 payment
|
| Centinel Spine | Prodisc C Vivo | $20 | 1 payment
|
| Biotronik | None | $17 | 1 payment
|
2022: $1,004
| Stryker | Xia 3 | $648 | 8 payments
|
| Si-Bone | None | $198 | 2 payments
|
| Nevro | Omnia | $107 | 1 payment
|
| Baxter Healthcare | Floseal | $36 | 1 payment
|
| NuVasive | Xlif | $16 | 1 payment
|
2021: $2,546
| Globus Medical | Excelsius Gps | $1,254 | 4 payments
|
| Stryker | Xia 3 | $360 | 3 payments
|
| Nevro | Omnia | $255 | 2 payments
|
| Centinel Spine | Prodisc C | $197 | 1 payment
|
| Medtronic | Intellis | $152 | 1 payment
|
| Royal Biologics | None | $76 | 2 payments
|
| NuVasive | Xlif | $68 | 3 payments
|
| Boston Scientific | Spectra Wavewriter (Refurbished) | $65 | 3 payments
|
| Si-Bone | Ifuse Implant | $59 | 2 payments
|
| Baxter Healthcare | Floseal | $48 | 1 payment
|
| Zimmer Biomet Holdings | Biomet Spinalpak | $12 | 1 payment
|
2020: $2,009
| Stryker | Cascadia | $1,724 | 17 payments
|
| Boston Scientific | Spectra Wavewriter | $151 | 3 payments
|
| Si-Bone | Ifuse Implant | $72 | 3 payments
|
| Royal Biologics | None | $26 | 1 payment
|
| Nevro | Senza Spinal Cord Stimulation System | $20 | 1 payment
|
| Medtronic USA | Vectris | $15 | 1 payment
|
2019: $3,168
| Stryker | Aero | $2,413 | 20 payments
|
| Medtronic USA | Adaptivestim | $220 | 6 payments
|
| NuVasive | Xlif | $197 | 3 payments
|
| Si-Bone | Ifuse Implant | $125 | 2 payments
|
| Royal Biologics | None | $112 | 3 payments
|
| Boston Scientific | General Pain Management | $87 | 1 payment
|
| Portola Pharmaceuticals | Andexxa | $14 | 1 payment
|
Professional record
- NPI
- 1508224064
- Licence
- NJ 25MA10265400New Jersey 25MA10265400: Active
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207T00000X (207T00000X)
- Mailing address
- 703 Main St Ste A2404, Paterson, NJ, 07503
- NPI first listed
- 2016-01-29
- NPI last updated
- 2018-12-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305